Keystone Financial Planning, Inc. / PFE
Keystone Financial Planning, Inc.’s Pfizer Inc Position
Does Keystone Financial Planning, Inc. own Pfizer Inc (PFE)? Yes — 246.4K shares worth $7M (+1.85% of its 13F portfolio) as of Q1 2026.
Position Value
$7M
Q1 2026
Shares
246.4K
% of Portfolio
+1.85%
Quarters Held
30
currently held
Position History PFE
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 246.4K | $7M | +1.85% |
| Q4 2025 | 246.4K | $6M | +1.78% |
| Q3 2025 | 254.0K | $6M | +1.88% |
| Q2 2025 | 254.9K | $6M | +1.87% |
| Q1 2025 | 256.2K | $6M | +1.93% |
| Q4 2024 | 256.2K | $7M | +2.11% |
| Q3 2024 | 256.7K | $7M | +2.25% |
| Q2 2024 | 256.9K | $7M | +2.38% |
| Q1 2024 | 257.2K | $7M | +2.31% |
| Q4 2023 | 265.4K | $8M | +2.52% |
| Q3 2023 | 245.9K | $8M | +2.85% |
| Q2 2023 | 232.2K | $9M | +2.85% |
| Q1 2023 | 218.0K | $9M | +3.03% |
| Q4 2022 | 55.6K | $3M | +0.96% |
| Q3 2022 | 56.0K | $2M | +0.94% |
| Q2 2022 | 64.0K | $3M | +1.18% |
| Q1 2022 | 55.5K | $3M | +0.96% |
| Q4 2021 | 55.0K | $3M | +1.11% |
| Q3 2021 | 231.6K | $10M | +3.62% |
| Q2 2021 | 237.4K | $9M | +3.37% |
| Q1 2021 | 240.5K | $9M | +3.25% |
| Q4 2020 | 235.3K | $9M | +3.59% |
| Q3 2020 | 228.5K | $8M | +4.05% |
| Q2 2020 | 226.6K | $7M | +3.65% |
| Q1 2020 | 223.4K | $7M | +4.17% |
| Q4 2019 | 214.4K | $8M | +3.75% |
| Q3 2019 | 207.5K | $7M | +3.56% |
| Q2 2019 | 199.6K | $9M | +4.23% |
| Q1 2019 | 199.9K | $8M | +4.19% |
| Q4 2018 | 198.3K | $9M | +4.84% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Keystone Financial Planning, Inc.’s full portfolio or all institutional holders of PFE.